Literature DB >> 9138111

Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.

J Marcoval1, A Moreno, J Graells, A Vidal, J M Escribà, M Garcia-Ramírez, A Fabra.   

Abstract

To study angiogenesis in early steps of melanoma progression, 113 cutaneous melanomas 1 mm or less in thickness were stained with Ulex europaeus lectin. Vascular density was determined in the areas of greatest vascularization. To avoid the effect of anatomic location, the quotient between vascular density at the tumor base and in normal skin (vascular ratio) was obtained in each case. Of these melanomas, 46 were immunohistochemically stained for the presence of vascular endothelial growth factor (VEGF). Positivity was scored from 1-4 by comparing staining of melanoma cells with keratinocytes. Vascular ratio values in vertical growth phase melanomas were higher than those in radial growth phase when counting per 200 or 400 magnification (2.29 +/- 1.3 and 2.48 +/- 1.5 for vertical growth phase and 1.34 +/- 0.62 and 1.41 +/- 0.83 for radial growth phase melanomas, respectively). This difference was statistically significant (p < 0.0001 and p < 0.001 at x200 and x400, respectively). Also, VEGF staining was stronger in vertical growth phase melanomas when compared with radial growth phase melanomas (Chi square, p < 0.025). In conclusion, our findings suggest that angiogenesis and VEGF expression are associated with the development of vertical growth phase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138111     DOI: 10.1111/j.1600-0560.1997.tb01583.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  33 in total

1.  Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia.

Authors:  Einar K Rofstad; Berit Mathiesen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density.

Authors:  Christian Marinaccio; Giuseppe Giudice; Eleonora Nacchiero; Fabio Robusto; Giuseppina Opinto; Gaetano Lastilla; Eugenio Maiorano; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2015-08-15       Impact factor: 3.984

3.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

Authors:  O Straume; L A Akslen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Angiogenesis and melanoma - from basic science to clinical trials.

Authors:  Maxine Sylvia Emmett; Daemon Dewing; Rowan Oliver Pritchard-Jones
Journal:  Am J Cancer Res       Date:  2011-08-08       Impact factor: 6.166

5.  S100A13 is a new angiogenic marker in human melanoma.

Authors:  Daniela Massi; Matteo Landriscina; Annamaria Piscazzi; Elena Cosci; Alek Kirov; Milena Paglierani; Claudia Di Serio; Vasileios Mourmouras; Stefano Fumagalli; Maurizio Biagioli; Igor Prudovsky; Clelia Miracco; Marco Santucci; Niccolò Marchionni; Francesca Tarantini
Journal:  Mod Pathol       Date:  2010-03-05       Impact factor: 7.842

Review 6.  Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?

Authors:  Iris Helfrich; Dirk Schadendorf
Journal:  Mol Oncol       Date:  2011-02-03       Impact factor: 6.603

7.  Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes.

Authors:  Traci A Wilgus; Annette M Matthies; Katherine A Radek; Julia V Dovi; Aime L Burns; Ravi Shankar; Luisa A DiPietro
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

8.  A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma.

Authors:  Valerie P Grignol; Thomas Olencki; Kiran Relekar; Cynthia Taylor; Amanda Kibler; Cheryl Kefauver; Lai Wei; Michael J Walker; Helen X Chen; Kari Kendra; William E Carson
Journal:  J Immunother       Date:  2011 Jul-Aug       Impact factor: 4.456

9.  The albino mutation of tyrosinase alters ocular angiogenic responsiveness.

Authors:  Michael S Rogers; Irit Adini; Aaron F McBride; Amy E Birsner; Robert J D'Amato
Journal:  Angiogenesis       Date:  2013-02-20       Impact factor: 9.596

10.  Angiogenesis and progression in human melanoma.

Authors:  R Ria; A Reale; A Castrovilli; G Mangialardi; F Dammacco; D Ribatti; A Vacca
Journal:  Dermatol Res Pract       Date:  2010-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.